Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Artificial Intelligence in Nuclear Medicine: Opportunities, Challenges, and Responsibilities Toward a Trustworthy Ecosystem.
Saboury B, Bradshaw T, Boellaard R, Buvat I, Dutta J, Hatt M, Jha AK, Li Q, Liu C, McMeekin H, Morris MA, Scott PJH, Siegel E, Sunderland JJ, Pandit-Taskar N, Wahl RL, Zuehlsdorff S, Rahmim A. Saboury B, et al. J Nucl Med. 2023 Feb;64(2):188-196. doi: 10.2967/jnumed.121.263703. Epub 2022 Dec 15. J Nucl Med. 2023. PMID: 36522184 Free PMC article.
The risk factors of prostate cancer: a multicentric case-control study in Iran.
Pourmand G, Salem S, Mehrsai A, Lotfi M, Amirzargar MA, Mazdak H, Roshani A, Kheirollahi A, Kalantar E, Baradaran N, Saboury B, Allameh F, Karami A, Ahmadi H, Jahani Y. Pourmand G, et al. Among authors: saboury b. Asian Pac J Cancer Prev. 2007 Jul-Sep;8(3):422-8. Asian Pac J Cancer Prev. 2007. PMID: 18159981 Free article.
Brain PET Imaging: Approach to Cognitive Impairment and Dementia.
Spano M, Roytman M, Aboian M, Saboury B, Franceschi A, Chiang GC. Spano M, et al. Among authors: saboury b. PET Clin. 2023 Jan;18(1):103-113. doi: 10.1016/j.cpet.2022.09.006. PET Clin. 2023. PMID: 36442959 Free PMC article. Review.
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results.
Hassan R, Butler M, O'Cearbhaill RE, Oh DY, Johnson M, Zikaras K, Smalley M, Ross M, Tanyi JL, Ghafoor A, Shah NN, Saboury B, Cao L, Quintás-Cardama A, Hong D. Hassan R, et al. Among authors: saboury b. Nat Med. 2023 Aug;29(8):2099-2109. doi: 10.1038/s41591-023-02452-y. Epub 2023 Jul 27. Nat Med. 2023. PMID: 37501016 Free PMC article. Clinical Trial.
147 results